Evercare Group, the operating platform held by the (ex-Abraaj) $1bn Evercare Health Fund, aims to open its Lagos hospital in December this year, Evercare Group CEO Massimiliano Colella tells HBI.
The temporary authorisation of telemedicine in Brazil will become permanent, HBI is told by a source close to the decision-making process, as the country's legislature is set to unveil a new law in Q4/1.
India's largest dialysis provider NephroPlus has acquired the fourth-largest private operator in the Philippines, while its home haemodialysis volumes have tripled during the pandemic in India, CEO Vikram Vuppala tells HBI.
NMC Health's administrators Alvarez & Marsal expect to complete a lender-led restructuring or sale of the group by April 2021, and sales of non-core assets - UK hospital chain Aspen Healthcare and international IVF group Eugin - much sooner. It's also revealed the COVID-19 impact on the group's healthcare services revenue.
Africa needs to come together to find a solution to the COVID crisis, which has proved to be as much an economic one as a healthcare one - and cannot and should not rely on help from outside. This was the view of an expert panel which convened online to discuss COVID-19, healthcare more generally, and African economics.
A health crisis leading to an economic downturn and a political crisis. Here is a case study of how COVID has hit Liberia based on the view of Gyude Moore, senior policy fellow at the Centre for Global Development, and former Minister of Public Work speaking on Saturday (October 10).
Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country.
An investigation has found that kickbacks are still rife in the Nigerian diagnostics market with some of the market's players artificially hiking prices so as to retain the extra costs.
The effect of the COVID crisis was evident in Indian hospital chain Apollo's Q1 results, announced on Monday. It reported a consolidated net loss of Rs 226 crore ($31m) for the quarter ending June 30, but there was a silver lining in the growth of it's pharmacy business.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
